Use of a collagen-elastin matrix as transport carrier system to transfer proliferating epidermal cells to human dermis in vitro.
This in vitro study describes a novel cell culture, transport, and transfer protocol that may be highly suitable for delivering cultured proliferating keratinocytes and melanocytes to large open skin wounds (e.g., burns). We have taken into account previous limitations identified using other keratinocyte transfer techniques, such as regulatory issues, stability of keratinocytes during transport (single cell suspensions undergo terminal differentiation), ease of handling during application, and the degree of epidermal blistering resulting after transplantation (both related to transplanting keratinocyte sheets). Large numbers of proliferating epidermal cells (EC) (keratinocytes and melanocytes) were generated within 10-14 days and seeded onto a three-dimensional matrix composed of elastin and collagen types I, III, and V (Matriderm®), which enabled easy and stable transport of the EC for up to 24 h under ambient conditions. All culture conditions were in accordance with the regulations set by the Dutch Central Committee on Research Involving Human Subjects (CCMO). As an in vitro model system for clinical in vivo transfer, the EC were then transferred from Matriderm onto human acellular dermis during a period of 3 days. After transfer the EC maintained the ability to regenerate into a fully differentiated epidermis containing melanocytes on the human dermis. Proliferating keratinocytes were located in the basal layer and keratin-10 expression was located in differentiating suprabasal layers similar to that found in human epidermis. No blistering was observed (separation of the epidermis from the basement membrane). Keratin-6 expression was strongly upregulated in the regenerating epidermis similar to normal wound healing. In summary, we show that EC-Matriderm contains viable, metabolically active keratinocytes and melanocytes cultured in a manner that permits easy transportation and contains epidermal cells with the potential to form a pigmented reconstructed epidermis. This in vitro study has produced a robust protocol that is ready for clinical studies in the future.
Department of Dermatology, VU University Medical Centre, Amsterdam, The Netherlands.
Taco
T
Waaijman
Melanie
M
Breetveld
Magda
M
Ulrich
Esther
E
Middelkoop
Rik J
RJ
Scheper
Susan
S
Gibbs
D000328:Adult; D000368:Aged; D002478:Cells, Cultured; D003094:Collagen / Q000648:ultrastructure; D020405:Dermis / Q000033:anatomy & histology*; D004549:Elastin / Q000648:ultrastructure; D000078404:Epidermal Cells; D004817:Epidermis / Q000033:anatomy & histology / Q000502:physiology; D005260:Female; D006801:Humans; D053550:Keratin-10 / Q000378:metabolism; D053553:Keratin-6 / Q000378:metabolism; D015603:Keratinocytes / Q000166:cytology / Q000637:transplantation; D008297:Male; D008544:Melanocytes / Q000166:cytology / Q000637:transplantation; D008875:Middle Aged; D012867:Skin / Q000033:anatomy & histology / Q000166:cytology / Q000378:metabolism; D017768:Skin, Artificial; D023822:Tissue Engineering
D053553:Keratin-6; D053550:Keratin-10; D003094:Collagen; D004549:Elastin